您好，欢迎来到易推广！ 请登录 免费注册

上海陶术生物科技有限公司 主营产品：生物试剂,实验服务等

当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示

企业档案

会员类型：会员

已获得易推广信誉   等级评定
139成长值

(0 -40)基础信誉积累，可浏览访问

(41-90)良好信誉积累，可接洽商谈

(91+  )优质信誉积累，可持续信赖

易推广会员：5年

工商认证 【已认证】

最后认证时间：

注册号： 【已认证】

法人代表： 【已认证】

企业类型：生产商 【已认证】

注册资金：人民币万 【已认证】

产品数：86101

参观次数：3228581

手机网站：http://m.yituig.com/c135739/

旗舰版地址：http://tsbiochem.app17.com

自主品牌

自主品牌

已选条件

  • T76784Tildrakizumab；替瑞奇珠单抗MK 3222|||SCH 900222；MK 3222|||SCH 900222

    Tildrakizumab (SCH 900222) is a potent humanized monoclonal antibody against IL-23 (p19 subunit). Tildrakizumab targets single-stranded IL-23 with a Kd value of 136 pM. Tildrakizumab can be used to study psoriasis and psoriasis.

    价 格：￥电议型 号：T76784产 地：中国大陆

  • T76783Moxetumomab pasudotox；化合物 Moxetumomab pasudotoxMoxetumomab pasudotox

    Moxetumomab Pasudotox (CAT 8015) is an anti-CD22 immunotoxin comprising an anti-CD22 Fv and Pseudomonas exotoxin, targeting the CD22 cell surface receptor present on various malignant B-cells. This compound is applicable in researching hairy cell leukemia (HCL) [1] [2] [3].

    价 格：￥电议型 号：T76783产 地：中国大陆

  • T76782Mogamulizumab；莫格利珠单抗KW-0761；KW-0761

    Mogamulizumab (KW-0761) is a monoclonal antibody against T cell CC chemokine receptor 4. Mogamulizumab has anticancer activity, eliminating tumor cells through antibody dependent cytotoxicity (ADCC), and can be used to study cancer, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL).

    价 格：￥电议型 号：T76782产 地：中国大陆

  • T76781Itolizumab；伊利组单抗EQ-001；EQ-001

    Itolizumab (Anti-Human CD6 Recombinant Antibody) is a recombinant anti-CD6 monoclonal antibody that humanizes the extracellular SRCR distal domain 1 of CD6. Itolizumab slows T cell proliferation and inhibits the production of pro-inflammatory cytokines. Itolizumab can be used to study conditions as diverse as psoriasis, rheumatoid arthritis (RA) and COVID-19 disease.

    价 格：￥电议型 号：T76781产 地：中国大陆

  • T76780Onartuzumab；奥那妥组单抗RG-3638|||PRO-14396|||MetMAb；RG-3638|||PRO-14396|||MetMAb

    Onartuzumab (MetMAb) is a humanized anti-tyrosine kinase c-MET monovalent monoclonal antibody.Onartuzumab has antitumor activity with inhibitory effects on HGF binding, receptor phosphorylation, and signal transduction.

    价 格：￥电议型 号：T76780产 地：中国大陆

  • T76779Brodalumab；布罗利尤单抗LP 0160|||KHK-4827|||AMG-827；LP 0160|||KHK-4827|||AMG-827

    Brodalumab (AMG 827) is a human monoclonal antibody targeting interleukin 17 receptor (IL-17R) IgG2, often used as an immunosuppressant in the treatment of psoriasis and psoriasis.

    价 格：￥电议型 号：T76779产 地：中国大陆

  • T76778Risankizumab；利散吉珠单抗Risankizumab rzaa|||SKYRIZI|||ABBV 066|||BI-655066；Risankizumab rzaa|||SKYRIZI|||

    Risankizumab (BI 655066) is a humanized IgG monoclonal antibody (Kd <10 pM) targeting the IL-23 p19 subunit. Risankizumab inhibits IL-17 production induced by human IL-23 in mouse splenocytes with an IC50 value of 2 pM.Risankizumab is used for the prevention and treatment of immune and inflammatory disorders such as psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis.

    价 格：￥电议型 号：T76778产 地：中国大陆

  • T76777Bermekimab；贝迈奇单抗MABp1；MABp1

    Bermekimab (MABp1) is a humanized monoclonal antibody against interleukin-1α (IL-1α).Bermekimab has potential anti-inflammatory activity to prevent skin inflammation.

    价 格：￥电议型 号：T76777产 地：中国大陆

  • T76776Emactuzumab；依瑞奈尤单抗RO 5509554|||RG 7155；RO 5509554|||RG 7155

    Emactuzumab(RG 7155) is a monoclonal antibody against colony-stimulating factor-1 receptor targeting tumor-associated macrophages (TAMs) Emactuzumab has antitumor activity and inhibits activation of colony-stimulating factor 1 receptor (CSF1R) Emactuzumab has a high affinity for CSF-1R with a Ki value of 0.2 nM. Emactuzumab blocks CSF-1R dimerization and can be used to study cancers such as diffuse tenosynovial giant cell tumor (dt-GCT).

    价 格：￥电议型 号：T76776产 地：中国大陆

  • T76775Fezakinumab；非扎奴单抗ILV 094；ILV 094

    Fezakinumab is a potent monoclonal antibody to interleukin-22 (IL-22). Fezakinumab can be used to study immune system diseases and inflammation-related conditions such as psoriasis, rheumatoid arthritis and atopic dermatitis.

    价 格：￥电议型 号：T76775产 地：中国大陆

  • T76774Ponsegromab；Ponsegromab单抗PF 06946860；PF 06946860

    Ponsegromab (PF 06946860) is a selective and effective humanized anti-GDF15 antibody inhibitor. Ponsegromab has anti-cachexic activity by binding to GDF15 to prevent its binding to GFRAL, thus disrupting GDF15/GFRAL mediated signaling. Ponsegromab has potential anticancer activity and can be used to treat cancer patients with cancer anorexia cachexia syndrome.

    价 格：￥电议型 号：T76774产 地：中国大陆

  • T76773Rolinsatamab；洛林妥单抗Rolinsatamab

    Rolinsatamab is a fully humanized selective monoclonal antibody that is a potent dual inhibitor of IL-4 and IL-13. Rolinsatamab chimeric antigen receptor sequence T cells. Rolinsatamab can be used to prevent and treat immune diseases.

    价 格：￥电议型 号：T76773产 地：中国大陆

  • T76772Nadunolimab；化合物 NadunolimabNadunolimab

    Nadunolimab, a human monoclonal IgG1 antibody, targets IL1RAP, inhibiting IL-1α and IL-1β signaling and inducing antibody-dependent cellular cytotoxicity. It is utilized in cancer research [1].

    价 格：￥电议型 号：T76772产 地：中国大陆

  • T76771Pivekimab；化合物 PivekimabPivekimab

    Pivekimab, a human IgG1 monoclonal antibody, targets interleukin 3 (IL-3) and CD123. It is utilized in researching blastocytic plasmacytoid dendritic cell tumor (BPDCN) [1].

    价 格：￥电议型 号：T76771产 地：中国大陆

  • T76770Camidanlumab；化合物 CamidanlumabCamidanlumab

    Camidanlumab (HuMax-TAC), a CD25 monoclonal antibody, selectively binds to the cell-surface antigen CD25, prevalent on numerous hematological tumors but minimally present on normal tissues. This specificity facilitates its use in developing antibody-drug conjugates (ADCs) aimed at treating diseases such as lymphoma and leukemia [1].

    价 格：￥电议型 号：T76770产 地：中国大陆

  • T76769Indusatumab；英度妥单抗Indusatumab

    Indusatumab (5F9 Monoclonal antibody) is an anti-human GUCY2C (Guanylate cyclase 2C) monoclonal antibody that can be used to synthesize antibody-drug conjugate.

    价 格：￥电议型 号：T76769产 地：中国大陆

  • T76768Pinatuzumab；化合物 PinatuzumabPinatuzumab

    Pinatuzumab, a CD22 monoclonal antibody, specifically targets the CD22 cell-surface antigen and is utilized in the synthesis of antibody-drug conjugates (ADCs) for researching a range of diseases, including non-Hodgkin lymphoma (NHL) [1] [2].

    价 格：￥电议型 号：T76768产 地：中国大陆

  • T76767Daxdilimab；化合物 DaxdilimabDaxdilimab

    Daxdilimab, an anti-ILT7 monoclonal antibody, targets the ILT7 cell surface molecule exclusive to pDC dendritic cells. It shows potential for treating acute lung injury (ALI) in COVID-19 infected patients, as indicated in research [1] [2].

    价 格：￥电议型 号：T76767产 地：中国大陆

  • T76766Mirvetuximab；米妥昔单抗M9346A；M9346A

    Mirvetuximab (M9346A) is a novel folate receptor α (FRα) monoclonal antibody targeting anti-FOLR1 (folate receptor 1). Mirvetuximab soravtansine is often conjugated with platinum compounds or other compounds to form antibody-drug conjugates for the treatment of ovarian cancer and other FRα-positive cancers.

    价 格：￥电议型 号：T76766产 地：中国大陆

  • T76765Veltuzumab；化合物 VeltuzumabVeltuzumab

    Veltuzumab (IMMU-106), a humanized anti-CD20 monoclonal antibody, exhibits a low EC50 value ranging from 0.08 to 0.09 μg/mL in the Daudi cell line. It is used in cancer research, specifically for non-Hodgkin lymphoma (NHL) [1].

    价 格：￥电议型 号：T76765产 地：中国大陆

12829303132333435363741下一页共41页

展台首页| 公司简介| 供应产品| 产品目录| 公司动态| 荣誉证书| 招聘信息| 技术中心| 联系我们| 会员管理

易推广  设计制作，未经允许翻录必究.Copyright(C) 2009 http://www.yituig.com, All rights reserved.

以上信息由企业自行提供，信息内容的真实性、准确性和合法性由相关企业负责，易推广对此不承担任何责任.   总访问量：3228581

中国彩虹热线

快速导航

返回顶部
在线咨询

提交